Literature DB >> 11724675

Prolonged course of toxic shock syndrome associated with methicillin-resistant Staphylococcus aureus enterotoxins G and I.

R D Meyer1, S R Monday, G A Bohach, S M Schlievert.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11724675     DOI： 10.1016/s1201-9712(01)90093-1

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN： 1201-9712            Impact factor:   3.623


× No keyword cloud information.
  5 in total

1.  egc-Encoded superantigens from Staphylococcus aureus are neutralized by human sera much less efficiently than are classical staphylococcal enterotoxins or toxic shock syndrome toxin.

Authors:  Silva Holtfreter; Kristin Bauer; Damien Thomas; Christine Feig; Vera Lorenz; Katharina Roschack; Erika Friebe; Kathleen Selleng; Sandra Lövenich; Timm Greve; Andreas Greinacher; Brigitte Panzig; Susanne Engelmann; Gérard Lina; Barbara M Bröker
Journal:  Infect Immun       Date:  2004-07       Impact factor: 3.441

2.  Prevalence of toxic shock syndrome toxin 1 (TSST-1)-producing strains of Staphylococcus aureus and antibody to TSST-1 among healthy Japanese women.

Authors:  Jeffrey Parsonnet; Richard V Goering; Melanie A Hansmann; Michaelle B Jones; Kumiko Ohtagaki; Catherine C Davis; Kyoichi Totsuka
Journal:  J Clin Microbiol       Date:  2008-06-11       Impact factor: 5.948

3.  Methicillin-resistant Staphylococcus aureus toxic shock syndrome.

Authors:  Sophie Jamart; Olivier Denis; Ariane Deplano; Georgios Tragas; Alexandra Vandergheynst; David De Bels; Jacques Devriendt
Journal:  Emerg Infect Dis       Date:  2005-04       Impact factor: 6.883

4.  Structurally designed attenuated subunit vaccines for S. aureus LukS-PV and LukF-PV confer protection in a mouse bacteremia model.

Authors:  Hatice Karauzum; Rajan P Adhikari; Jawad Sarwar; V Sathya Devi; Laura Abaandou; Christian Haudenschild; Mahta Mahmoudieh; Atefeh R Boroun; Hong Vu; Tam Nguyen; Kelly L Warfield; Sergey Shulenin; M Javad Aman
Journal:  PLoS One       Date:  2013-06-07       Impact factor: 3.240

Review 5.  Staphylococcal bicomponent pore-forming toxins: targets for prophylaxis and immunotherapy.

Authors:  M Javad Aman; Rajan P Adhikari
Journal:  Toxins (Basel)       Date:  2014-03-04       Impact factor: 4.546
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.